BioNxt Solutions Inc. (FRA:BXT)

Revenue by Product

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Analytical Testing and Consulting Services	26.99K
Analytical Testing and Consulting Services Growth	-92.75%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Germany	16.35K
Germany Growth	-16.23%
Austria	6.22K
Austria Growth	-92.38%
Switzerland	4.41K
Switzerland Growth	24.86%